Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.61%
)
US TECH 100
29,229.20
(
1.84%
)
Dow Jones
50,461.68
(
-0.23%
)
Brent Oil
95.45
(
-1.59%
)
Bitcoin
75,624.13
(
-0.29%
)
News Focus
News Focus
Post# of 26138
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jadite

Send PM Follow Ignore
Followers 4
Posts 1270
Boards Moderated 0
Alias Born 05/17/2012

jadite

Re: nutsyprofessor post# 25333

Tuesday, 04/16/2013 8:35:46 PM

Tuesday, April 16, 2013 8:35:46 PM

Post# of 26138
Sorry. Meant this as a new message:

HFA Healthcare bought up the last batch of Intrinsa and has jacked up the price to consumers of this now "unlicensed medicine" in the UK.
This last batch is set to expire in July 2014.
http://www.numarknet.com/news/change-in-status-of-intrinsa-patches

HFA Healthcare states that the decision to discontinue was purely commercial and not about safety.
http://www.hfa-specials.co.uk/presc-healthcare-professionals/

I wonder which big pharma paid Warner Chilcott to pull Intrinsa? I bet HFA Healthcare knows.




Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today